Company intelligence / Profile preview

ENBIOSIS Biotechnology

London, England, United Kingdomenbiosis.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

ENBIOSIS has demonstrated clinically validated results with its AI-powered personalized nutrition platform—showing measurable improvements in symptoms of IBS (~78% success) and chronic constipation (~83% success) through dietary modulation of the gut microbiome. The company’s liquid-biopsy diagnostic products are non-invasive tools under active research/development. Its technology has been recognized by top-tier journals and awards within the field.

Therapeutic areas: Gastroenterology
Modalities: Microbiome-based diagnostics and therapeutics (including prebiotics/probiotics)AI-driven personalized nutrition and supplement recommendationsLiquid biopsy biomarkers for early disease detectionBacteriophage therapy (in development)Smart microbiome transplant (in development)
Industry: Biotech

Drug pipeline

3 assets

en-masculine

Preclinical

2 more assets in the full pipeline.

Request access →

Partnerships

Collaborations with academic institutions in Medicon Valley regionstrategic partnerships with healthcare providers/practitioners internationallysupported by UK government grants/funding initiatives.

Beyond the preview

Go deeper on ENBIOSIS Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ENBIOSIS Biotechnology.

Explore the full profile